Stock Ticker

  • Loading stock data...

Heat Biologics Inc (NASDAQ:HTBX) Appoints Dr. Jeff Hutchins As New Chief Operating Officer

Heat Biologics Inc (NASDAQ:HTBX) has appointed Dr. Jeff Hutchins as its Chief Operating Officer. Dr. Hutchins was previously CSO and SVP, Pre-clinical Development with the company. In his new role, he will lead product development initiatives for Heat Biologic and its Pelican Therapeutics subsidiary firm. The management view Jeff Wolf, the CEO of Heat Biologics, […]

Heat Biologics, Inc. (NASDAQ:HTBX) Manages To Beat Phase 1 In Lung Cancer Combo Experiment

Heat Biologics, Inc. (NASDAQ:HTBX) reported that it is has managed the safety and efficacy endpoint in the Phase 1b trial. It has achieved to get the approval to proceed to Phase 2. The experiment details The company is leading in development of immunotherapies which are meant to activate the immune systems of patients against cancer. […]

Sign Up To Get Our Latest Stocks Alerts